45 related articles for article (PubMed ID: 10912783)
21. Expression of genes coding for proteoglycans and Wilms' tumour susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells.
Gulyás M; Dobra K; Hjerpe A
Differentiation; 1999 Oct; 65(2):89-96. PubMed ID: 10550542
[TBL] [Abstract][Full Text] [Related]
22. Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells.
Dobra K; Nurminen M; Hjerpe A
Anticancer Res; 2003; 23(3B):2435-44. PubMed ID: 12894525
[TBL] [Abstract][Full Text] [Related]
23. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium.
Gulyás M; Hjerpe A
J Pathol; 2003 Apr; 199(4):479-87. PubMed ID: 12635139
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and expression of mRNA encoding for different versican splice variants is related to the aggregation of human epithelial mesothelioma cells.
Syrokou A; Dobra K; Tzanakakis GN; Hjerpe A; Karamanos NK
Anticancer Res; 2002; 22(6C):4157-62. PubMed ID: 12553048
[TBL] [Abstract][Full Text] [Related]
25. Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome.
Kumar-Singh S; Jacobs W; Dhaene K; Weyn B; Bogers J; Weyler J; Van Marck E
J Pathol; 1998 Nov; 186(3):300-5. PubMed ID: 10211120
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans.
Dobra K; Andäng M; Syrokou A; Karamanos NK; Hjerpe A
Exp Cell Res; 2000 Jul; 258(1):12-22. PubMed ID: 10912783
[TBL] [Abstract][Full Text] [Related]
27. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.
Theocharis AD; Skandalis SS; Tzanakakis GN; Karamanos NK
FEBS J; 2010 Oct; 277(19):3904-23. PubMed ID: 20840587
[TBL] [Abstract][Full Text] [Related]
28. [The role of syndecan and tenascine during tooth development. Review o the literature].
Bucci P; Canfora M; Cocozza G; Pannone G; Sorrentino F
Minerva Stomatol; 1996 Jun; 45(6):259-66. PubMed ID: 8965771
[TBL] [Abstract][Full Text] [Related]
29. The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors.
Szatmári T; Dobra K
Front Oncol; 2013 Dec; 3():310. PubMed ID: 24392351
[TBL] [Abstract][Full Text] [Related]
30. [Hyaluronan aggregating proteoglycans].
Bobiński R; Olczyk K; Krzyzowska-Bobińska E
Postepy Biochem; 1998; 44(3):245-51. PubMed ID: 10022044
[No Abstract] [Full Text] [Related]
31. [Hyaluronan synthase: functional analysis of hyaluronan by gene modification].
Itano N; Yoshida M; Kimata K
Tanpakushitsu Kakusan Koso; 1998 Dec; 43(16 Suppl):2387-93. PubMed ID: 9883663
[No Abstract] [Full Text] [Related]
32. Microbial-induced regulation of syndecan expression: important host defense mechanism or an opportunity for pathogens?
Smith MF; Gautam JK; Black SG; Ernst PB
ScientificWorldJournal; 2006 Apr; 6():442-5. PubMed ID: 16604254
[No Abstract] [Full Text] [Related]
33. Proteoglycans as potential biomarkers in odontogenic tumors.
Gómez-Herrera Z; Molina-Frechero N; Damián-Matsumura P; Bologna-Molina R
J Oral Maxillofac Pathol; 2018; 22(1):98-103. PubMed ID: 29731564
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
